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Abstract
Intake of individual antioxidants has been related to a lower risk of type 2 diabetes. However, the overall diet may contain 
many antioxidants with additive or synergistic effects. Therefore, we aimed to determine associations between total dietary 
antioxidant capacity and risk of type 2 diabetes, prediabetes and insulin resistance. We estimated the dietary antioxidant 
capacity for 5796 participants of the Rotterdam Study using a ferric reducing ability of plasma (FRAP) score. Of these par-
ticipants, 4957 had normoglycaemia and 839 had prediabetes at baseline. We used covariate-adjusted proportional hazards 
models to estimate associations between FRAP and risk of type 2 diabetes, risk of type 2 diabetes among participants with 
prediabetes, and risk of prediabetes. We used linear regression models to determine the association between FRAP score and 
insulin resistance (HOMA-IR). We observed 532 cases of incident type 2 diabetes, of which 259 among participants with 
prediabetes, and 794 cases of incident prediabetes during up to 15 years of follow-up. A higher FRAP score was associated 
with a lower risk of type 2 diabetes among the total population (HR per SD FRAP 0.84, 95% CI 0.75; 0.95) and among 
participants with prediabetes (HR 0.85, 95% CI 0.73; 0.99), but was not associated with risk of prediabetes. Dietary FRAP 
was also inversely associated with HOMA-IR (β − 0.04, 95% CI − 0.06; − 0.03). Effect estimates were generally similar 
between sexes. The findings of this population-based study emphasize the putative beneficial effects of a diet rich in anti-
oxidants on insulin resistance and risk of type 2 diabetes.
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Introduction
Oxidative stress is commonly regarded as an important 
contributing factor in the pathogenesis of type 2 diabetes 
mellitus [1]. Generally, oxidative stress is the result of an 
excess of reactive oxygen species (ROS), which are partially 
reduced forms of oxygen [2]. While ROS are considered 
essential for normal physiological function, an excess of 
ROS can lead to structural damage to important biomol-
ecules and impairment of their function [2, 3]. A biological 
defense mechanism against excess ROS is formed by anti-
oxidants. These bioactive compounds may prevent the gen-
eration of ROS or scavenge free radicals [1, 2]. Antioxidants 
can be endogenous, i.e. naturally occurring in the human 
body, such as uric acid and glutathione; or exogenous, in 
which case they are mainly derived from the diet [2]. Exog-
enous antioxidants, such as vitamin E and carotenoids, form 
an indispensable complementary component of the natural 
antioxidant defense system [4].
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A high dietary intake of antioxidants may lower oxidative 
stress and thereby lower the risk of diseases related to oxida-
tive stress, such as type 2 diabetes. In line with this, a higher 
intake of certain nutrients with antioxidative properties has 
been associated with a lower risk of type 2 diabetes mel-
litus [5, 6]. In addition, serum levels of certain antioxidants 
have been shown to be inversely related to plasma glucose 
levels and measures of insulin resistance [7, 8]. However, 
the majority of previous studies on this topic have investi-
gated individual antioxidant components only, as opposed to 
using a comprehensive measure of total dietary antioxidant 
capacity. The diet can contain many components with anti-
oxidative properties which may have additive or synergistic 
effects, and intake of individual antioxidants may therefore 
not reflect the total antioxidant capacity of the diet [9]. The 
concept of total dietary antioxidant capacity aims to cap-
ture overall effects of antioxidants from dietary compounds 
and thereby facilitates studying the effects of antioxidants 
in the context of complex diets [10]. Major contributors to 
the overall antioxidant capacity of the diet are coffee, tea, 
red wine and various types of fruits (blueberries, grapes, 
oranges) and vegetables (cabbage species, spinach, broccoli) 
[11, 12].
To our knowledge, only one previous study, among 
women only, examined the overall dietary antioxidant capac-
ity in relation to type 2 diabetes [13]. Furthermore, dietary 
antioxidants have not been studied in relation to intermediate 
stages in the development of type 2 diabetes, such as insulin 
resistance or prediabetes. Therefore, we aimed to determine 
the association between dietary antioxidant capacity and risk 
of type 2 diabetes, risk of prediabetes and insulin resistance 
in a large population-based cohort with up to 15 years of 
follow-up.
Methods
Study design and population
The general design and objectives of the Rotterdam Study 
have been described in detail elsewhere [14]. In brief, the 
Rotterdam Study (RS) is a population-based cohort which 
started in 1990 with the inclusion of 7893 inhabitants of 
the Ommoord district in the city of Rotterdam, the Nether-
lands, aged 55 years or older (sub-cohort RS-I). In 2000, the 
cohort was extended with a second sub-cohort (sub-cohort 
RS-II) consisting of 3011 participants who had moved into 
the Ommoord district or had become 55 years of age since 
the inception of the first sub-cohort. A further extension of 
the total cohort was initiated in 2006, when 3932 residents 
of the Ommoord district aged 45–54 years were included in 
a third sub-cohort (sub-cohort RS-III). These participants 
were interviewed at home and received extensive physical 
examinations at the Rotterdam Study research facility at 
baseline, which are repeated every 3–4 years. The Rotter-
dam Study has received approval from the Medical Ethics 
Committee of Erasmus University Medical Center and from 
the review board of the Dutch Ministry of Health, Welfare 
and Sports. All participants have provided written informed 
consent [14].
Population for analysis
Of the 14,926 participants in the Rotterdam Study, valid 
dietary data were available at the baseline examination round 
for each cohort for a total of 9701 participants [15]. Among 
the 5225 participants without valid dietary data, 5141 indi-
viduals had no dietary data available, and 84 were judged to 
have invalid dietary data because their daily energy intake 
did not exceed 500 kcal or was greater than 5000 kcal. Of 
the 9701 participants with valid dietary data, 1126 were 
excluded because they had prevalent cardiovascular disease 
(defined as a history of stroke, heart failure, myocardial 
infarction or revascularisation procedure) and 415 were 
excluded because they had prevalent cancer. Of the remain-
ing 8160 participants, 1682 had no information on glucose 
status available and 682 had prevalent type 2 diabetes. Thus, 
our population for analysis consisted of 5796 individuals. 
Information on fasting serum glucose and insulin, used to 
calculate homeostatic model assessment of insulin resistance 
(HOMA-IR), was available for 5422 of these individuals.
Dietary assessment
Dietary data were collected by means of a semi-quantita-
tive food frequency questionnaire (FFQ), administered by 
a trained interviewer, during the baseline examination of 
the participants. For sub-cohorts RS-II and RS-I, a two-
step approach was used in assessing dietary data. First, par-
ticipants completed a self-administered checklist on which 
foods were consumed at least twice a month during the pre-
ceding year. The completed checklist was used as a basis 
for the structured FFQ interview, performed by a trained 
dietician, about consumption frequencies and amounts at 
the Rotterdam Study research facility. The FFQ used in these 
sub-cohorts consisted of 170 items and was developed for 
and validated among the elderly [16]. For sub-cohort RS-
III-I, collection of dietary data was performed by means of 
a single self-administered, 389-item, semi-quantitative FFQ 
which was based on an existing validated FFQ developed for 
Dutch adults [17, 18]. Portion sizes in grams per day were 
estimated using standard household measures. Food intake 
data were subsequently converted into daily energy and 
nutrient intake using the Dutch Food Composition Tables 
of 1993 for RS-I-1, 2001 for RS-II-1, and 2006 for RS-III-1.
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Assessment of total dietary antioxidant capacity
In order to estimate the total dietary antioxidant capacity, 
we used the Antioxidant Food Table published by Carlsen 
and colleagues, who determined the antioxidant content of 
over 3100 types of food and beverages using a ferric reduc-
ing ability of plasma (FRAP) assay [10]. The FRAP assay 
measures the reduction of ferric ion  (Fe3+) to ferrous ion 
 (Fe2+) and has been used extensively in nutrition science [2, 
19]. The FRAP value of each type of food extracted from the 
Antioxidant Food Table (mmol/100 g) was multiplied by its 
consumption frequency for every participant, and we then 
summed these values across all dietary sources of antioxi-
dants to calculate a FRAP score for every participant repre-
senting the total dietary antioxidant capacity. Nutrition sci-
entists from Wageningen University, the Netherlands, were 
consulted to determine the closest Dutch food equivalent 
for products that had different FRAP measurements listed 
for different manufacturers in the Antioxidant Food Table. 
No detailed data were available on the consumption of food 
supplements in our study, so we did not include food sup-
plements in the calculation of the total dietary antioxidant 
capacity.
Ascertainment of type 2 diabetes mellitus, 
prediabetes, normoglycaemia and HOMA‑IR
Fasting blood samples were obtained from participants dur-
ing their visit to the Rotterdam Study research facility by 
means of venipuncture. The samples were stored at − 80 °C 
in 5 mL aliquots. Glucose levels were measured using the 
glucose hexokinase method within 1 week of sampling [20]. 
In 2008, insulin levels were measured in these samples by 
means of electrochemiluminescence immunoassay technol-
ogy using a Roche Modular Analytics E170 analyzer (Roche 
Diagnostics GmbH, Mannheim, Germany). We calculated 
HOMA-IR as the product of fasting serum glucose (mmol/L) 
and fasting serum insulin (mU/L) levels divided by 22.5. 
All measurements were performed at the clinical chemis-
try laboratory of Erasmus University Medical Center. We 
obtained data on the use of glucose-lowering medication 
through structured home interviews as well as pharmacy 
dispensing records. In accordance with WHO guidelines and 
the Rotterdam Study protocol, we defined type 2 diabetes 
as a fasting plasma glucose level ≥ 7 mmol/L, a non-fasting 
plasma glucose level ≥ 11.1 mmol/L or the use of blood 
glucose lowering medication. We defined prediabetes as a 
fasting plasma glucose level > 6.0 mmol/L and < 7 mmol/L, 
or a non-fasting plasma glucose level > 7.7 mmol/L and 
< 11.1 mmol/L. We defined normoglycaemia as a fasting 
plasma glucose level ≤ 6 mmol/L [21]. At baseline and 
throughout follow-up, we ascertained prediabetes and type 
2 diabetes cases using records from general practitioners, 
hospital discharge letters and the glucose measurements per-
formed as part of the Rotterdam Study [22]. Two physicians 
independently assessed all potential prediabetes and type 2 
diabetes cases and consulted an endocrinologist in case of 
disagreement [22]. Serum glucose levels and incident cases 
of type 2 diabetes and prediabetes were recorded from the 
third examination round of the first cohort (RS-I-3) and 
the baseline examination rounds from the second and third 
cohort (RS-II-1 and RS-III-1) onwards. Hence, these rounds 
were used as the baseline for follow-up in our analyses.
Covariates
We considered the following potentially confounding vari-
ables for our analyses, based on theory and previous lit-
erature: age, sex, body mass index (BMI), hypertension, 
dyslipidemia, highest attained level of education, degree of 
physical activity, smoking status, total daily energy intake, 
daily alcohol intake and degree of adherence to guidelines 
for a healthy diet. Anthropomorphic characteristics were 
recorded during participants’ visits to the Rotterdam Study 
research facility. We calculated BMI as weight in kilograms 
divided by squared height in meters. We defined hyperten-
sion as the use of antihypertensive medication, having a 
systolic blood pressure ≥ 140 mmHg or having a diastolic 
blood pressure ≥ 90 mmHg. Blood pressure was recorded as 
the mean value of two blood pressure readings at the right 
upper arm in sitting position, separated by 2 min, using a 
random-zero sphygmomanometer. We defined dyslipidemia 
as a serum total cholesterol level > 6.5 mmol/L or use of 
lipid-lowering medication. Serum total cholesterol was 
determined in fasting blood samples using the CHOD-PAP 
method (Monotest Cholesterol kit, Boehringer Mannheim 
Diagnostica, Germany) [23]. We determined the use of 
antihypertensive and lipid-lowering drugs through home 
interviews and consulting pharmacy dispensing records. 
Smoking status and the highest attained level of education 
were also ascertained during home interviews. We catego-
rized participants as never smokers, former smokers or cur-
rent smokers. Education level was split into four categories: 
primary education, lower or intermediate general education 
or lower vocational education, intermediate vocational edu-
cation or higher general education and higher vocational 
education or university education. We calculated total daily 
energy intake (kcal/day) and daily alcohol intake (g/day) 
from data obtained from the FFQs. The overall dietary pat-
tern was taken into account using a diet quality score reflect-
ing adherence to dietary guidelines. This dietary pattern 
index, described by Voortman et al. [15], reflected intake 
of 14 food groups, including fruits and vegetables, whole 
grains and whole grain products, legumes, nuts, dairy, fish, 
tea, unsaturated fats and oils, red and processed meat, sugar-
containing beverages and salt. The final index was a score 
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ranging from 0 to 14 with a higher score reflecting a higher 
diet quality. The degree of physical activity was assessed 
by means of the LASA Physical Activity Questionnaire and 
a modified version of the Zutphen Study Physical Activity 
Questionnaire, and was expressed as metabolic equivalent 
of task (MET) hours per week based on time spent in light, 
moderate and vigorous activity [24]. To account for the use 
of two different questionnaires, we divided participants into 
quartiles of physical activity based on questionnaire-specific 
standard deviation scores.
Statistical analysis
Cox proportional hazards regression was performed with 
total dietary antioxidant capacity as the primary independent 
variable and incident prediabetes or incident type 2 diabetes 
as the response variable. The time scale in these models is 
follow-up time in years to either clinical endpoint, death, 
loss-to-follow-up or January 1st 2012—whichever came 
first. As main analysis, we first investigated associations of 
FRAP score with incident type 2 diabetes. Subsequently, 
we analyzed this trajectory in more detail by investigating 
incident prediabetes among normoglycaemic individuals and 
incident type 2 diabetes among individuals with prediabetes. 
We used multivariable linear regression models to assess the 
association between FRAP score and HOMA-IR. In these 
linear regression models, HOMA-IR was transformed using 
the natural logarithm to better approximate a normal distri-
bution. For all outcomes, we constructed models adjusted 
only for age, sex and cohort (model 1), models adjusted 
additionally for BMI, hypertension, dyslipidemia, highest 
level of education attained, physical activity and smoking 
status (model 2), and models further adjusted for degree of 
adherence to dietary guidelines, total daily energy intake and 
daily alcohol intake (model 3). We accounted for potential 
non-linear relations between the independent and dependent 
variables by including three-knot natural cubic splines in our 
regression models when their use resulted in a significantly 
better model fit. Potential effect modification by age, sex or 
smoking status was investigated by introducing the product 
of these variables and the total dietary antioxidant capac-
ity to our regression models. We ran separate models if the 
interaction terms were statistically significant at the P < 0.10 
level. As sensitivity analyses, we repeated our analyses with 
a modified FRAP score calculated without the contribution 
of coffee because some discussion remains on the bioavail-
ability of the antioxidants found in coffee, and we also per-
formed our analyses excluding the first year of follow-up 
[13]. Five-fold multiple imputation using predictive mean 
matching was performed to account for missing values of 
covariates (ranging from 0 to 4.3%). Our results are pre-
sented as pooled hazard ratios (HRs) with 95% confidence 
intervals (95% CIs) obtained after multiple imputation for 
a standard deviation increment in total dietary antioxidant 
capacity. Statistical analyses were performed using R version 
3.4.1 (The R Foundation for Statistical Computing, Vienna, 
Austria).
Results
The baseline characteristics of the total study population 
(n = 5796) and the subgroups of men (n = 2266) and women 
(n = 3530) are displayed in Table 1. The major contributors 
to FRAP in our study were intake of coffee, fruit, vegeta-
bles, tea and chocolate. A comparison between participants 
who were and were not included in the analysis of this 
study based on missing data is presented in Supplemen-
tary Table 1. Because we observed statistical interactions 
between FRAP score and sex on risk of prediabetes (P value 
for interaction 0.06) and on HOMA-IR (P value for interac-
tion 0.01), we stratified all our analyses by sex. The mean 
(SD) FRAP score was 24.0 (9.0) for the total population, 
25.1 (9.8) for men and 23.2 (8.4) for women.
Of all 5796 individuals eligible for analysis, 532 devel-
oped type 2 diabetes over a mean follow-up duration of 
8.1 years (incidence rate 11.4 per 1000 person-years). We 
observed an association between a higher FRAP score and 
a lower risk of type 2 diabetes, which remained statistically 
significant after adjusting for metabolic and socio-economic 
factors in model 2 (HR 0.85, 95% CI 0.76; 0.95) and further 
adjustment for dietary factors in model 3 (HR 0.84, 95% CI 
0.75; 0.95). For incident type 2 diabetes there was no statisti-
cal interaction between dietary antioxidant capacity and sex, 
and indeed we observed similar effect estimates among men 
(HR 0.84, 95% CI 0.71; 1.00) and women (HR 0.83, 95% 
CI 0.70; 0.99) after adjustment for all covariates (Table 2). 
Of the 839 individuals with prediabetes at baseline, 259 
developed type 2 diabetes over a mean follow-up duration 
of 7.4 years (incidence rate 41.5 per 1000 person-years). We 
also found a significant association between FRAP score and 
incident type 2 diabetes in this subgroup (model 3; HR 0.85, 
0.73; 0.99), with similar effect estimates among men and 
women (P value for interaction 0.90) (Table 2).
Over a mean follow-up duration of 7.7 years, 794 of the 
4957 individuals with normoglycaemia at baseline devel-
oped prediabetes (incidence rate 20.9 per 1000 person-
years). FRAP score was not significantly associated with 
incident prediabetes (model 3; HR 0.93, 95% CI 0.84; 1.02). 
However, after stratification by sex (P value for interaction 
0.06), we observed a significant inverse association among 
men (model 3; HR 0.84, 95% CI 0.72; 0.98) whereas among 
women, we observed no association (HR 0.99, 95% CI 0.87; 
1.12) (Table 2).
Finally, in the multivariable linear regression models, 
we observed that FRAP score was significantly inversely 
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associated with HOMA-IR after adjustment for age, sex 
and cohort [model 1; regression coefficient (β) − 0.04, 95% 
CI − 0.06; − 0.03]. This association remained significant 
after adjusting for all covariates (model 3; β − 0.04, 95% CI 
− 0.06; − 0.03). In the analysis stratified for sex (P value for 
interaction 0.01), the association between FRAP score and 
HOMA-IR was significant among both men (β − 0.03, 95% 
CI − 0.06; − 0.01) and women (β − 0.05, 95% CI − 0.07; 
− 0.03), although slightly stronger among women (Table 3).
In sensitivity analyses, we observed that upon exclusion of 
participants with less than 1 year of follow-up, the associa-
tions between dietary antioxidant capacity and incident type 
2 diabetes remained significant (HR 0.86, 95% CI 0.76; 0.98) 
(Supplementary Table 2). However, among individuals with 
prediabetes, the association was no longer significant (HR 
0.90, 95% CI 0.76; 1.05). Exclusion of participants with less 
than 1 year of follow-up did not change our conclusion with 
regards to incident prediabetes, which remained significantly 
associated with dietary antioxidant capacity only among men 
(HR 0.82, 95% CI 0.70; 0.97). After excluding coffee from 
the calculation of the FRAP score, the associations observed 
previously attenuated and FRAP score was no longer signifi-
cantly associated with any of the outcomes (Supplementary 
Tables 3, 4). Finally, in stage-specific analyses of HOMA-IR, 
we observed similar associations of dietary antioxidant capac-
ity with HOMA-IR among participants with normoglycaemia 
(β − 0.04, 95% CI − 0.05; − 0.02) and participants with pre-
diabetes (β − 0.03, 95% CI − 0.07; 0.002) (Supplementary 
Table 5).
Table 1  Baseline characteristics of the study population
Variables are presented as mean (SD) unless otherwise indicated
a Variable is presented as median (interquartile range) because it did not follow a normal distribution. Differences between men and women were 
assessed using Student’s T-tests in the case of normally distributed continuous variables, χ2-tests in the case of categorical variables and Mann–
Whitney U tests in the case of non-normally distributed continuous variables. The statistics reported above represent the dataset after multiple 
imputation
Overall
(n = 5796)
Men
(n = 2266)
Women
(n = 3530)
P value for dif-
ference between 
sexes
Age (years) 64.2 (9.2) 63.4 (8.7) 64.6 (9.5) < 0.001
Body mass index (kg/m2) 26.9 (4.1) 26.6 (3.3) 27.1 (4.5) < 0.001
Dyslipidemia
 No 3818 (65.9%) 1640 (72.4%) 2178 (61.7%) 0.846
 Yes 1978 (34.1%) 626 (27.6%) 1352 (38.3%)
Hypertension
 No 2394 (41.3%) 940 (41.5%) 1454 (41.2%) < 0.001
 Yes 3402 (58.7%) 1326 (58.5%) 2076 (58.8%)
Physical activity (metabolic equivalents of task—hours/week)a
 LASA questionnaire (RS-I and RS-II) 81.8 (57.5) 70.6 (56.2) 88.5 (57.2) < 0.001
 Zutphen questionnaire (RS-III) 45.0 (64.7) 38.7 (55.8) 52.4 (69.1) < 0.001
 Total 71.2 (63.8) 59.8 (58.9) 77.8 (62.5) < 0.001
Education
 Primary 650 (11.2%) 183 (8.1%) 467 (13.2%) < 0.001
 Lower vocational 2398 (41.4%) 625 (27.6%) 1773 (50.2%)
 Intermediate vocational 1660 (28.6%) 827 (36.5%) 833 (23.6%)
 Higher vocational or university 1088 (18.8%) 631 (27.8%) 457 (12.9%)
Smoking
 Never 1932 (33.3%) 397 (17.5%) 1535 (43.5%) < 0.001
 Former 2527 (43.6%) 1242 (54.8%) 1285 (36.4%)
 Current 1337 (23.1%) 627 (27.7%) 710 (20.1%)
Dietary guideline score 6.8 (1.9) 6.3 (1.8) 7.1 (1.9) < 0.001
Alcohol consumption (g/day)a 6.6 (18.1) 13.0 (23.4) 3.44 (12.3) < 0.001
Daily energy intake (kcal/day) 2143.8 (622.4) 2436.3 (633.3) 1955.9 (537.1) < 0.001
FRAP score 24.0 (9.0) 25.1 (9.8) 23.2 (8.4) < 0.001
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Discussion
In this population-based cohort, we observed that a higher 
total dietary antioxidant capacity is associated with a 
lower risk of type 2 diabetes, both in the total population 
and among those with prevalent prediabetes. In further 
stage-specific analyses, we found that a higher total dietary 
antioxidant capacity is also associated with lower risk of 
incident prediabetes among men, but not among women, 
and with a lower HOMA-IR among both men and women.
Our results are in line with the findings of previous stud-
ies which have investigated individual antioxidant compo-
nents in relation to type 2 diabetes [5, 6, 25]. Montonen and 
colleagues demonstrated that various types of tocopherols 
were associated with a reduced risk of type 2 diabetes over 
Table 2  Associations between total dietary antioxidant capacity, risk of type 2 diabetes, risk of type 2 diabetes among prediabetics and risk of 
prediabetes
Results are presented as hazard ratio (95% confidence interval) for a standard deviation increment in FPAP score
a Model 1: adjusted for age, sex and Rotterdam Study cohort
b Model 2: model 1 + body mass index, hypertension, dyslipidaemia, highest level of education attained, physical activity and smoking status
c Model 3: model 2 + degree of adherence to dietary guidelines, total daily energy intake and daily alcohol intake
Total population
(n = 5796, n cases = 532)
P value Men
(n = 2266, n cases = 218)
P value Women
(n = 3530, n cases = 314)
P value
Incident type 2 diabetes
 Model  1a 0.86 (0.76; 0.96) 0.01 0.85 (0.72; 1.00) 0.05 0.87 (0.74; 1.02) 0.09
 Model  2b 0.85 (0.76; 0.95) 0.004 0.82 (0.70; 0.97) 0.02 0.86 (0.73; 1.01) 0.07
 Model  3c 0.84 (0.75; 0.95) 0.01 0.84 (0.71; 1.00) 0.06 0.83 (0.70; 0.99) 0.03
Total population
(n = 839, n cases = 259)
P value Men
(n = 398, n cases = 114)
P value Women
(n = 441, n cases = 145)
P value
Incident type 2 diabetes among participants with prediabetes
 Model  1a 0.84 (0.73; 0.97) 0.02 0.85 (0.70; 1.04) 0.11 0.82 (0.66; 1.04) 0.10
 Model  2b 0.85 (0.73; 0.98) 0.03 0.83 (0.69; 1.01) 0.06 0.85 (0.68; 1.07) 0.18
 Model  3c 0.85 (0.73; 0.99) 0.03 0.86 (0.70; 1.05) 0.13 0.81 (0.63; 1.04) 0.10
Total population
(n = 4957, n cases = 794)
P value Men
(n = 1868, n cases = 297)
P value Women
(n = 3089, n cases = 497)
P value
Incident prediabetes
 Model  1a 0.94 (0.86; 1.03) 0.17 0.85 (0.74; 0.98) 0.02 1.01 (0.90; 1.14) 0.85
 Model  2b 0.92 (0.84; 1.01) 0.09 0.83 (0.72; 0.95) 0.01 1.00 (0.89; 1.13) 0.99
 Model  3c 0.93 (0.84; 1.02) 0.13 0.84 (0.72; 0.98) 0.02 0.99 (0.87; 1.12) 0.87
Table 3  Associations between 
total dietary antioxidant 
capacity and homeostatic model 
assessment of insulin resistance 
(HOMA-IR)
Results are presented as regression coefficient (95% confidence interval) for a standard deviation increment 
in FPAP score
a Model 1: adjusted for age, sex and Rotterdam Study cohort
b Model 2: model 1 + body mass index, hypertension, dyslipidaemia, highest level of education attained, 
physical activity and smoking status
c Model 3: model 2 + degree of adherence to dietary guidelines, total daily energy intake and daily alcohol 
intake
Total population
(n = 5422)
P value Men
(n = 2135)
P value Women
(n = 3287)
P value
Model  1a − 0.04
(− 0.06; − 0.03)
< 0.001 − 0.03
(− 0.06; − 0.01)
0.005 − 0.06
(− 0.08; − 0.03)
< 0.001
Model  2b − 0.04
(− 0.05; − 0.03)
< 0.001 − 0.03
(− 0.05; − 0.01)
0.001 − 0.05
(− 0.07; − 0.03)
< 0.001
Model  3c − 0.04
(− 0.06; − 0.03)
< 0.001 − 0.03
(− 0.06; − 0.01)
0.002 − 0.05
(− 0.07; − 0.03)
< 0.001
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23 years of follow-up [5]. Similarly, Salonen and colleagues 
observed that low vitamin E levels predispose individuals 
to developing type 2 diabetes [25]. Sluijs and colleagues 
found that carotenoid intake was inversely related to risk of 
type 2 diabetes [6]. Furthermore, our findings confirm previ-
ous studies which have found associations between dietary 
antioxidant capacity and measures of insulin resistance [7, 
8]. Only one previous study has examined the total dietary 
antioxidant capacity in relation to type 2 diabetes [13]. In 
line with our findings, this study observed a strongly signifi-
cant inverse association, but was performed among women 
only and did not investigate dietary antioxidant capacity in 
relation to stage-specific transitions from normoglycaemia 
to type 2 diabetes. Thus, our study is the first that inves-
tigated total dietary antioxidant capacity among both men 
and women in relation to incident type 2 diabetes, includ-
ing intermediate endpoints such as prediabetes and insulin 
resistance to capture the full trajectory from normoglycae-
mia to type 2 diabetes.
Dietary antioxidants may directly affect glucose homeo-
stasis in multiple ways. It has been hypothesized that oxida-
tive stress activates the NF-κB pathway and various protein 
kinase pathways [26]. Activation of these pathways may 
inhibit signaling between insulin receptors and the glucose 
transport system, which contributes to the development of 
insulin resistance [26, 27]. Through suppressing the forma-
tion of ROS, and thereby lowering oxidative stress, dietary 
antioxidants may improve insulin sensitivity. Furthermore, 
it has been demonstrated in animal models that antioxidants 
can suppress apoptosis of pancreatic β-cells induced by oxi-
dative stress [28]. Therefore, dietary antioxidants may also 
help in sustaining β-cell function and preventing damage to 
these cells.
We found that dietary antioxidant capacity was not sig-
nificantly associated with risk of prediabetes in the total 
study population. However, we did find significant asso-
ciations between dietary antioxidant capacity and incident 
type 2 diabetes and HOMA-IR among both participants with 
normoglycaemia and those with prediabetes. Because the 
relative contribution of pancreatic β-cell dysfunction to the 
pathogenesis of type 2 diabetes increases as hyperglycaemia 
worsens, dietary antioxidants may more strongly affect risk 
of type 2 diabetes among individuals with prediabetes trough 
preserving β-cell function rather than attenuating insulin 
resistance [29]. These findings also suggest that a diet with 
a high antioxidant capacity will exert its protective effects 
against type 2 diabetes regardless of whether or not predia-
betes is already present. It could therefore be hypothesized 
that the mechanisms underlying the protective effects of 
dietary antioxidants are related to both early-phase phenom-
ena in the pathogenesis of type 2 diabetes (such as insulin 
resistance) and later-phase phenomena (such as β-cell dys-
function). However, the exact nature of these mechanisms 
is currently unclear, and further research is necessary to 
confirm our findings.
We observed significant modification of our effect esti-
mates by sex for some of the analyses. However, sex dif-
ferences were not consistent among outcomes: the associa-
tion between total dietary antioxidant capacity and incident 
prediabetes was significant among men, but not among 
women, whereas associations with insulin resistance were 
slightly stronger among women compared to men. The latter 
observation is in line with findings reported by Okubo and 
colleagues [8]. Potential sex differences in associations of 
dietary antioxidant capacity with earlier stages in the devel-
opment of type 2 diabetes could be caused by differences in 
visceral fat mass between men and women, because visceral 
fat mass is positively associated with the degree of oxida-
tive stress and differs according to sex [30, 31]. However, 
further research into the nature of potential sex differences 
is warranted, especially because we report for the first time 
that these appear to be stage-specific.
Our effect estimates decreased in magnitude when the 
contribution of coffee was excluded from the total dietary 
antioxidant capacity, suggesting that part of the association 
is explained by coffee intake. Coffee is commonly regarded 
as a major constituent of the total dietary antioxidant capac-
ity. A recent study found that coffee intake captured 54% 
of the variation in total antioxidant intake among Norwe-
gian women [12]. Likewise, in our study population, coffee 
constituted on average 49% of the total dietary antioxidant 
capacity. The fact that coffee forms an integral component 
of the total dietary antioxidant capacity probably accounts 
for the significant attenuation we observed in our effect 
estimates when coffee intake was excluded from the FRAP 
score. In relation to this, coffee intake has also been shown 
to be inversely related to risk of type 2 diabetes [32–34]. 
Disregarding coffee, the most important contributors to total 
dietary antioxidant capacity in our study were fruit and veg-
etables. Indeed, it has been demonstrated that increased fruit 
and vegetable consumption is associated with a lower risk 
of type 2 diabetes [35]. The findings of our study there-
fore further underline the putative beneficial health effects 
of coffee, fruit and vegetable consumption. With regards to 
tea and chocolate consumption, which also contributed to 
dietary FRAP in our study population, both of these food 
groups have also been associated with lower risk of type 2 
diabetes [36, 37].
The main strengths of our study include its prospective 
design, the large sample size and the long-duration of fol-
low-up. This enabled us to study the association between 
total dietary antioxidant capacity and various endpoints 
in the pathway from normoglycaemia to type 2 diabetes 
with a large pool of validated cases. We were also able to 
adjust for an extensive set of socio-economic, metabolic 
and dietary confounders, including a measure of overall 
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diet quality, to minimize the chance of residual confound-
ing influencing our results. However, approximately 95% 
of our study population was of Caucasian ethnicity, and 
all participants were aged 45 years and older. Therefore, 
caution should be taken in generalizing our results to other 
populations. Furthermore, we calculated the total dietary 
antioxidant capacity based on an antioxidant food database 
developed in Norway. We cannot rule out the possibil-
ity that differences between Norway and the Netherlands 
with regards to the geographical origin of food may have 
introduced error in our estimates of the true antioxidant 
capacity. In addition, we had no information on the cook-
ing methods that participants used, which may also affect 
the antioxidant content of food. It is also conceivable that 
the use of different FFQs and different food composition 
tables in our study caused differences between participants 
in the assessment of their FRAP score. However, regard-
ing the use of different FFQs, since the use of these dif-
ferent questionnaires coincided with the start of a new 
study cohort, and “cohort” was included in our analyses 
as a confounder, our analyses should to a large degree be 
adjusted for this effect. Finally, we only estimated dietary 
antioxidant capacity from intake of foods, and were unable 
to account for the use of food supplements in our study.
In conclusion, total dietary antioxidant capacity was 
related to a lower risk of type 2 diabetes, but not risk of pre-
diabetes, and was inversely associated with insulin resistance 
in this population-based cohort of individuals aged 45 years 
and older. Our findings emphasize the putative beneficial 
health effects of a diet rich in antioxidants with regards to the 
prevention of type 2 diabetes. Further studies could contrib-
ute to a better understanding of the stage-specific associa-
tions we have observed and unravel underlying mechanisms.
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